News
Altitude Lab Launches Pre-seed Venture Fund, Anchored by Recursion CEO Chris Gibson, Enabling SBIR-awarded Biotechs Hit by Funding Gap to Build in Salt Lake City
Altitude Lab has launched the Altitude Lab Fund to support early-stage biotech startups impacted by federal funding cuts. In partnership with Recursion, the fund offers $100,000–$250,000, lab space, and accelerator access to high-potential SBIR-reviewed companies. Led by industry leaders, it aims to bridge funding gaps, support underrepresented founders, and strengthen Salt Lake City’s biotech hub.
